comparemela.com
  1. Home
  2. Live Updates
  3. முதலீட்டாளர் நிகழ்வு - Breaking News

Latest Breaking News On - முதலீட்டாளர் நிகழ்வு - Page 1 : comparemela.com

Mirati Therapeutics Announces Positive Phase 2 Topline Results for Investigational Adagrasib in Patients with KRAS G12C-Mutated Advanced Non-Small Cell Lung Cancer

Mirati Therapeutics Announces Positive Phase 2 Topline Results for Investigational Adagrasib in Patients with KRAS G12C-Mutated Advanced Non-Small Cell Lung Cancer
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

Priyanka shahCharlesm baumTemre johnsonExchange commissionEuropean society of medical oncologyDrug administrationMirati therapeutics incMirati therapeuticsNew drug applicationInvestor eventMedical oncologyNon small cell lung cancerபிரியாங்க ஷாபரிமாற்றம் தரகுஐரோப்பிய சமூகம் ஆஃப் மருத்துவ புற்றுநோயியல்மிரட்டி சிகிச்சை இன்க்

Mirati Therapeutics Presents Positive Clinical Data with Investigational Adagrasib as Monotherapy and in Combination with Cetuximab in Patients with KRAS G12C-Mutated Colorectal Cancer

Mirati Therapeutics Presents Positive Clinical Data with Investigational Adagrasib as Monotherapy and in Combination with Cetuximab in Patients with KRAS G12C-Mutated Colorectal Cancer
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

Jared weissPriyanka shahCharlesm baumTemre johnsonExchange commissionEuropean society for medical oncology congressUniversity of north carolinaMirati therapeutics incMirati therapeuticsPresidential symposiumEuropean societyMedical oncology congressNorth carolina chapelClinical resultsConfidence intervalInvestor event

Mirati Therapeutics Presents Positive Clinical Data with Investigational Adagrasib as Monotherapy and in Combination with Cetuximab in Patients with KRAS G12C-Mutated Colorectal Cancer

Mirati Therapeutics Presents Positive Clinical Data with Investigational Adagrasib as Monotherapy and in Combination with Cetuximab in Patients with KRAS G12C-Mutated Colorectal Cancer
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

Jared weissPriyanka shahCharlesm baumTemre johnsonExchange commissionEuropean society for medical oncology congressUniversity of north carolinaMirati therapeutics incMirati therapeuticsPresidential symposiumEuropean societyMedical oncology congressNorth carolina chapelClinical resultsConfidence intervalInvestor event

Mirati Therapeutics to Host Virtual Investor Event on Monday, September 20, 2021

Mirati Therapeutics to Host Virtual Investor Event on Monday, September 20, 2021
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

Jared weissPriyanka shahSitravatinib sitraTemre johnsonNivolumab nivoExchange commissionEuropean society of medical oncologyMirati therapeutics incMirati therapeuticsInvestor eventMedical oncologyCentral european summer timePatients with colorectal cancer harboringPresidential symposiumWith nonsquamousSmall cell lung cancer

Wallbox To Host Investor Event On Tuesday, August 10, 2021

Wallbox To Host Investor Event On Tuesday, August 10, 2021
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

United statesComunidad autonoma de catalunaEnric asunciMatt simonciniMasud rabbaniDon runkleBob remenarEduard castaOriol ribaJustin mirroSimon boagDan huberNicole nasonTom lasordaMitch quainAnders pettersson

vimarsana © 2020. All Rights Reserved.